Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 896,000 | 702,200 | 555,000 | 634,700 | 622,800 |
| Receivables | 1,727,800 | 1,565,400 | 1,592,000 | 1,761,100 | 1,872,500 |
| Inventories | 1,223,800 | 1,199,400 | 1,197,000 | 1,306,000 | 1,340,500 |
| Other current assets | 370,200 | 349,900 | 366,000 | 385,400 | 421,400 |
| TOTAL | $4,217,800 | $3,816,900 | $3,710,000 | $4,087,200 | $4,257,200 |
| Non-Current Assets | |||||
| PPE Net | 3,245,400 | 3,054,700 | 3,119,000 | 3,047,200 | 3,149,300 |
| Intangibles | 3,027,300 | 2,903,000 | 2,986,000 | 3,048,100 | 3,264,600 |
| Other Non-Current Assets | 239,600 | 158,700 | 164,000 | 372,700 | 399,201 |
| TOTAL | $6,512,300 | $6,116,400 | $6,269,000 | $6,468,000 | $6,813,101 |
| Total Assets | $10,730,100 | $9,933,300 | $9,979,000 | $10,555,200 | $11,070,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 347,400 | 55,800 | 91,000 | 140,100 | 138,900 |
| Accounts payable and accrued liabilities | 1,038,000 | 959,000 | 1,061,000 | 1,096,000 | 1,167,600 |
| TOTAL | $3,240,200 | $3,056,100 | $2,952,000 | $3,255,800 | $3,320,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,367,900 | 3,490,500 | 3,585,000 | 3,284,400 | 3,475,900 |
| Other Non-Current Liabilities | 1,269,100 | 1,278,900 | 1,301,400 | 1,142,700 | 1,239,000 |
| TOTAL | $4,790,900 | $4,938,300 | $4,983,000 | $4,831,500 | $5,083,400 |
| Total Liabilities | $8,031,100 | $7,994,400 | $7,935,000 | $8,087,300 | $8,403,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 996,855 | 999,130 | 1,002,634 | 1,009,430 | 1,011,465 |
| Common Shares | 732,900 | 732,900 | 733,000 | 732,900 | 732,900 |
| Retained earnings | 12,392,400 | 11,844,500 | 11,760,000 | 11,480,900 | 11,185,600 |
| Other shareholders' equity | -2,280,000 | -2,587,400 | -2,543,000 | -2,012,500 | -1,672,900 |
| TOTAL | $2,699,000 | $1,938,900 | $2,044,000 | $2,467,900 | $2,666,600 |
| Total Liabilities And Equity | $10,730,100 | $9,933,300 | $9,979,000 | $10,555,200 | $11,070,300 |